| Literature DB >> 29426280 |
Huilan Shi1, Junya Jia2, Dong Li2, Li Wei2, Wenya Shang2, Zhenfeng Zheng3.
Abstract
BACKGROUND: Precise renal histopathological diagnosis will guide therapy strategy in patients with lupus nephritis. Blood oxygen level dependent (BOLD) magnetic resonance imaging (MRI) has been applicable noninvasive technique in renal disease. This current study was performed to explore whether BOLD MRI could contribute to diagnose renal pathological pattern.Entities:
Mesh:
Substances:
Year: 2018 PMID: 29426280 PMCID: PMC5806290 DOI: 10.1186/s12882-017-0787-z
Source DB: PubMed Journal: BMC Nephrol ISSN: 1471-2369 Impact factor: 2.388
Comparisons of clinical data and laboratory data in 12 patients with lupus nephritis
| Clinical Indexes | Case 1 | Case 2 | Case 3 | Case 4 | Case 5 | Case 6 | Case 7 | Case 8 | Case 9 | Case 10 | Case 11 | Case 12 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Clinical Data | ||||||||||||
| Age (15–52 years) | ||||||||||||
| Time between diagnosis of LN (months) | 36 | 180 | 48 | 84 | 156 | 24 | 24 | 2 | 2 | 33 | 0.25 | 1 |
| Systolic blood pressure (mmHg) | 130 | 130 | 130 | 160 | 140 | 110 | 120 | 140 | 100 | 150 | 120 | 120 |
| Diastolic blood pressure (mmHg) | 80 | 80 | 80 | 110 | 90 | 70 | 80 | 80 | 50 | 80 | 80 | 80 |
| Nephrotic syndrome | + | – | – | + | + | + | – | – | – | + | – | + |
| SLEDAI | 12 | 23 | 18 | 33 | 25 | 19 | 14 | 26 | 17 | 12 | 27 | 21 |
| Laboratory data | ||||||||||||
| Hemoglobin (g/l) | 78 | 103 | 116 | 100 | 131 | 138 | 105 | 81 | 98 | 133 | 92 | 108 |
| Urine protein (g/24 h) | 6.79 | 0.34 | 1.46 | 4.76 | 7.14 | 6.51 | 1.15 | 2.08 | 0.81 | 4.67 | 1.87 | 4.63 |
| Serum creatinine (umol/L) | 62 | 43 | 59 | 93 | 32 | 27 | 56 | 73 | 47 | 37 | 136 | 56 |
| eGFR (ml/min/1.73 m2) | 98 | 113 | 105 | 62 | 108 | 124 | 113 | 80 | 120 | 113 | 39 | 131 |
| Serum albumin (g/dl) | 16 | 34 | 33 | 30 | 16 | 26 | 36 | 21 | 29 | 26 | 28 | 12 |
| anti-ds-DNA | + | – | + | + | + | + | + | + | + | – | + | + |
| anti-Sm | – | + | – | – | – | – | – | + | + | – | + | – |
| anti-Ro52 | – | + | + | – | – | + | + | – | – | + | + | + |
| anti-SSA | + | – | + | – | + | + | – | – | – | + | + | + |
| anti-SSB | – | – | – | – | – | – | + | – | + | + | + | – |
| anti-RNP | + | + | – | – | + | – | – | + | – | + | + | + |
| anti-cardiolipin antibody | – | – | – | – | – | – | – | – | – | – | + | – |
| C3 (g/l) | 59.2 | 72.3 | 51.6 | 49.2 | 55.83 | 53.7 | 67.4 | 35.8 | 33.1 | 57.7 | 26.3 | 28.5 |
| C4 (g/l) | 16.2 | 15.7 | 11.6 | 11.1 | 7.82 | 5.06 | 13.4 | 1.76 | 2.67 | 14.2 | 3.3 | 3.76 |
| ESR (mm/h) | 46 | 29 | 35 | 35 | 39 | 45 | 37 | 53 | 52 | 44 | 40 | 48 |
ANA anti-nuclear antibodies, RNP ribonucleoprotein, SLEDAI systemic lupus erythematosus disease activity index, SSA Sjogren’s syndrome A antigen, SSB Sjogren’s syndrome B antigen, eGFR estimated glomerular filtrate
Comparisons of renal pathological parameter scores in 12 patients with lupus nephritis
| Light microscopy | Case 1 | Case 2 | Case 3 | Case 4 | Case 5 | Case 6 | Case 7 | Case 8 | Case 9 | Case 10 | Case 11 | Case 12 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Number of glomeruli | 14 | 28 | 41 | 16 | 21 | 16 | 17 | 27 | 21 | 15 | 15 | 21 |
| Activity Index | ||||||||||||
| Glomerular cell proliferation | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 2 |
| Leucocyte exudation | 1 | 2 | 1 | 2 | 2 | 1 | 2 | 2 | 0 | 1 | 1 | 1 |
| Karyorrhexis and fibrinoid necrosis | 1 | 2 | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 1 | 2 |
| Cellular crescents | 2 | 1 | 3 | 2 | 1 | 0 | 1 | 1 | 1 | 3 | 1 | 2 |
| Hyaline deposits | 1 | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 2 | 2 |
| Interstitial inflammation | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 |
| Al score | 9 | 11 | 10 | 9 | 8 | 4 | 6 | 7 | 4 | 8 | 9 | 11 |
| Chronicity Index | ||||||||||||
| Glomerular sclerosis | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
| Fibrous crescents | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tubular atrophy | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 1 |
| Interstitial fibrosis | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Cl score | 3 | 3 | 2 | 2 | 2 | 2 | 2 | 3 | 2 | 2 | 3 | 2 |
| Pathological diagnosis | IV-G (A/C) + V | IV-G (A/C) + V | IV-G (A/C) | IV-G (A/C) + V | III-(A/C) + V | III-(A/C) + V | III-(A/C) + V | III-(A/C) | III-(A/C) | IV-G (A/C) | IV-G (A/C) | IV-G (A/C) + V |
Fig. 1BOLD-MRI and renal pathological pictures of kidneys. Representative magnetic resonance images of a III type LN (a,e,i), III + V type (b,f,j), IV type (c,g,k) and IV + V type (d,h,l) LN patients. The BOLD-MRI pictures were expressed as pseudo-color maps. For example, blue represents the areas of lowest R2* values and oxyhemoglobin levels, whereas green, yellow, and red, in that order, represent increasing R2* values and higher oxyhemoglobin levels on the colored R2* map
Fig. 2Decision tree model for predicting class III and class IV of lupus nephritis with CHIAD algorithm
Comparisons of predictive capability of the three algorithm models
| Diagnosis Test Parameters | Decision Tree Model | Line Discriminant Model | Logistic Regression Model |
|---|---|---|---|
| Sensitivity | 0.718a,b | 0.595c | 0.787 |
| Specificity | 0.639b | 0.637c | 0.380 |
| Accuracy | 0.685a,b | 0.613 | 0.618 |
| AUROCC | 0.765a b | 0.629c | 0.662 |
AUROCC area under the ROC curve
a Decision tree model vs Line discriminant model, p < 0.001
b Decision tree model vs Logistic regression model, p < 0.001
c Line discriminant model vs Logistic regression model, p < 0.001
Comparisons of primary renal pathological patterns predicted by the three algorithm models on the basis of predicted probability of R2* data
| Case Number | Pathological Diagnosis | Predicted by Decision Tree Model (percentage/number, %/n) | Decision Tree Mode Result | Predicted by Line Discriminate Model (percentage/number, %/n) | Line Discriminate Mode Result | Predicted by Logistic Regression Model (percentage/number, %/n) | Logistic Regression Mode Result | |||
|---|---|---|---|---|---|---|---|---|---|---|
| III Type | IV Type | III Type | IV Type | III Type | IV Type | |||||
| Case 1 | IV | 25% (74) | 75% (226) | IV | 15% (44) | 85% (256) | IV | 3% (8) | 97% (292) | IV |
| Case 2 | IV | 42% (125) | 58% (175) | IV | 88% (263) | 12% (37) | III | 56% (176) | 44% (124) | III |
| Case 3 | IV | 40% (119) | 60% (181) | IV | 62% (186) | 38% (114) | III | 32% (95) | 78% (205) | IV |
| Case 4 | IV | 34% (103) | 66% (197) | IV | 63% (188) | 37% (112) | III | 38% (113) | 62% (187) | IV |
| Case 5 | III | 55% (166) | 45% (134) | III | 65% (195) | 35% (105) | III | 37% (112) | 63% (188) | IV |
| Case 6 | III | 60% (180) | 40% (120) | III | 81% (243) | 19% (57) | III | 55% (164) | 45% (136) | III |
| Case 7 | III | 74% (221) | 26% (79) | III | 88% (263) | 12% (37) | III | 70% (209) | 30% (91) | III |
| Case 8 | III | 73% (218) | 27% (82) | III | 65% (194) | 35% (106) | III | 24% (71) | 76% (229) | IV |
| Case 9 | III | 58% (173) | 42% (127) | III | 20% (61) | 80% (239) | IV | 5% (14) | 95% (286) | IV |
| Case 10 | IV | 23% (70) | 76% (230) | IV | 44% (133) | 56% (167) | IV | 17% (50) | 83% (250) | IV |
| Case 11 | IV | 22% (67) | 78% (233) | IV | 1% (4) | 99% (296) | IV | 0% (1) | 100% (299) | IV |
| Case 12 | IV | 11% (34) | 89% (266) | IV | 11% (33) | 89% (267) | IV | 1% (4) | 99% (296) | IV |
Comparisons of secondary renal pathological patterns predicted by the decision tree models on the basis of predicted probability of R2* data
| Case Number | Pathological Diagnosis | Predicted Primary Class (percentage/number, %/n) | Decision Tree Model Result | Predicted Secondary Class (percentage/number, %/n) | Decision Tree Model Result | ||
|---|---|---|---|---|---|---|---|
| III Type | IV Type | Homogeneity | Heterogeneity | ||||
| Case 1 | IV-G (A/C) + V | 25% (74) | 75% (226) | IV | 17% (50) | 83% (250) | IV-G (A/C) + V |
| Case 2 | IV-G (A/C) + V | 42% (125) | 58% (175) | IV | 5% (16) | 95% (284) | IV-G (A/C) + V |
| Case 3 | IV-G (A/C) | 40% (119) | 60% (181) | IV | 35% (104) | 65% (196) | IV-G (A/C) + V |
| Case 4 | IV-G (A/C) + V | 34% (103) | 66% (197) | IV | 30% (89) | 70% (211) | IV-G (A/C) + V |
| Case 5 | III-(A/C) + V | 55% (166) | 45% (137) | III | 20% (61) | 80% (239) | III-(A/C) + V |
| Case 6 | III-(A/C) + V | 60% (180) | 40% (120) | III | 6% (19) | 94% (281) | III-(A/C) + V |
| Case 7 | III-(A/C) + V | 74% (221) | 26% (79) | III | 13% (39) | 87% (261) | III-(A/C) + V |
| Case 8 | III-(A/C) | 73% (218) | 27% (82) | III | 60% (179) | 40% (121) | III-(A/C) |
| Case 9 | III-(A/C) | 58% (173) | 42% (127) | III | 93% (280) | 7% (20) | III-(A/C) |
| Case 10 | IV-G (A/C) | 23% (70) | 76% (230) | IV | 64% (192) | 36% (108) | IV-G (A/C) |
| Case 11 | IV-G (A/C) | 22% (67) | 78% (238) | IV | 93% (279) | 7% (21) | IV-G (A/C) |
| Case 12 | IV-G (A/C) + V | 11% (34) | 89% (266) | IV | 19% (58) | 81% (242) | IV-G (A/C) + V |